Soluble epoxide hydrolase deficiency attenuates neointima formation in the femoral cuff model of hyperlipidemic mice

Arterioscler Thromb Vasc Biol. 2010 May;30(5):909-14. doi: 10.1161/ATVBAHA.110.204099. Epub 2010 Mar 11.

Abstract

Objective: Epoxyeicosatrienoic acids (EETs) have antiinflammatory effects and are required for normal endothelial function. The soluble epoxide hydrolase (sEH) metabolizes EETs to their less active diols. We hypothesized that knockout and inhibition of sEH prevents neointima formation in hyperlipidemic ApoE(-/-) mice.

Methods and results: Inhibition of sEH by 12-(3-adamantan-1-yl-ureido) dodecanoic acid or knockout of the enzyme significantly increased plasma EET levels. sEH activity was detectable in femoral and carotid arteries. sEH knockout or inhibition resulted in a significant reduction of neointima formation in the femoral artery cuff model but not following carotid artery ligation. Although macrophage infiltration occurred abundantly at the site of cuff placement in both sEH(+/+) and sEH(-/-), the expression of proinflammatory genes was significantly reduced in femoral arteries from sEH(-/-) mice. Moreover, an in vivo 5-bromo-2'-deoxyuridine assay revealed that smooth muscle cell proliferation at the site of cuff placement was attenuated in sEH knockout and sEH inhibitor-treated animals.

Conclusion: These observations suggest that inhibition of sEH prevents vascular remodeling in an inflammatory model but not in a blood flow-dependent model of neointima formation.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adamantane / analogs & derivatives*
  • Adamantane / pharmacology
  • Animals
  • Apolipoproteins E / deficiency
  • Apolipoproteins E / genetics
  • Arachidonic Acids / metabolism
  • Atherosclerosis / enzymology
  • Atherosclerosis / etiology
  • Atherosclerosis / genetics
  • Atherosclerosis / pathology
  • Atherosclerosis / prevention & control*
  • Carotid Artery Diseases / enzymology
  • Carotid Artery Diseases / pathology
  • Carotid Artery Diseases / prevention & control
  • Carotid Artery, Common / drug effects
  • Carotid Artery, Common / enzymology
  • Carotid Artery, Common / pathology
  • Cell Proliferation / drug effects
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology*
  • Epoxide Hydrolases / antagonists & inhibitors*
  • Epoxide Hydrolases / deficiency*
  • Epoxide Hydrolases / genetics
  • Epoxide Hydrolases / metabolism
  • Femoral Artery / drug effects*
  • Femoral Artery / enzymology
  • Femoral Artery / injuries
  • Femoral Artery / pathology
  • Hyperlipidemias / complications*
  • Hyperlipidemias / enzymology
  • Hyperlipidemias / genetics
  • Hyperplasia
  • Inflammation Mediators / metabolism
  • Lauric Acids / pharmacology*
  • Macrophages / pathology
  • Mice
  • Mice, Inbred C57BL
  • Mice, Knockout
  • Muscle, Smooth, Vascular / drug effects*
  • Muscle, Smooth, Vascular / enzymology
  • Muscle, Smooth, Vascular / injuries
  • Muscle, Smooth, Vascular / pathology
  • Tunica Intima / drug effects*
  • Tunica Intima / enzymology
  • Tunica Intima / injuries
  • Tunica Intima / pathology

Substances

  • 12-(3-adamantan-1-ylureido)dodecanoic acid
  • Apolipoproteins E
  • Arachidonic Acids
  • Enzyme Inhibitors
  • Inflammation Mediators
  • Lauric Acids
  • Epoxide Hydrolases
  • Adamantane